Stockholm - Free Realtime Quote SEK
Prostatype Genomics AB (publ) (PROGEN.ST)
1.7600
-0.0200
(-1.12%)
As of 9:00:02 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-44,709
-44,709
-29,138
-27,693
-16,078.2100
Investing Cash Flow
-8,356
-8,356
-8,566
--
-2,499.6410
Financing Cash Flow
59,751
59,751
28,911
18,853
23,045.2390
End Cash Position
9,420
9,420
2,682
11,489
20,329.1750
Capital Expenditure
-7,863
-7,863
-8,562
--
-2,499.6410
Issuance of Capital Stock
66,151
66,151
18,111
--
--
Issuance of Debt
8,825
8,825
16,200
19,253
23,245.2390
Repayment of Debt
-15,225
-15,225
-5,400
-400
-200
Free Cash Flow
-52,572
-52,572
-37,700
-27,693
-18,577.8510
12/31/2021 - 11/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade